Clinical Practice

Use the tool below to view all available Global Oncology Academy Series

Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
CME/CE
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
0.25 credits
- Cem Akin, MD, PhD
0.25 credits
Redefining First-Line Therapy in mCSPC: Applying Evidence in Practice
Redefining First-Line Therapy in mCSPC: Applying Evidence in Practice
Project Oncology®
Redefining First-Line Therapy in mCSPC: Applying Evidence in Practice
- Brian P. McDonough, MD, FAAFP
- William Oh, MD
Guideline Updates Redefining Squamous Cell Carcinoma of the Anal Canal Care
Guideline Updates Redefining Squamous Cell Carcinoma of the Anal Canal Care
Project Oncology®
Guideline Updates Redefining Squamous Cell Carcinoma of the Anal Canal Care
- Charles Turck, PharmD, BCPS, BCCCP
- Aparna R. Parikh, MD
ctDNA-Guided Bladder Preservation in Muscle-Invasive Bladder Cancer
ctDNA-Guided Bladder Preservation in Muscle-Invasive Bladder Cancer
Project Oncology®
ctDNA-Guided Bladder Preservation in Muscle-Invasive Bladder Cancer
- Charles Turck, PharmD, BCPS, BCCCP
- Pooja Ghatalia, MD
The Changing Landscape of CRC Screening and Prevention
The Changing Landscape of CRC Screening and Prevention
On the Frontlines of Colorectal Cancer
The Changing Landscape of CRC Screening and Prevention
- Ryan Quigley
- Samuel Muench, MD
CRC Screening Strategies: Balancing Accuracy, Access, and Adherence
CRC Screening Strategies: Balancing Accuracy, Access, and Adherence
On the Frontlines of Colorectal Cancer
CRC Screening Strategies: Balancing Accuracy, Access, and Adherence
- Ryan Quigley
- Samuel Muench, MD
The Epigenetics of Lung Cancer Dormancy and Relapse
The Epigenetics of Lung Cancer Dormancy and Relapse
Project Oncology®
The Epigenetics of Lung Cancer Dormancy and Relapse
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
CME/CE
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
0.25 credits
- Mariana C. Castells, MD, PhD
- Tsewang Tashi, MD
0.25 credits
Embedding Video Guidance in CRC Screening Reminders Fails to Increase FIT Return Rates
Embedding Video Guidance in CRC Screening Reminders Fails to Increase FIT Return Rates
Clinician's Roundtable
Embedding Video Guidance in CRC Screening Reminders Fails to Increase FIT Return Rates
Personalized Risk Communication and Its Effect on CRC Screening Choice
Personalized Risk Communication and Its Effect on CRC Screening Choice
Clinician's Roundtable
Personalized Risk Communication and Its Effect on CRC Screening Choice
Advancing Care for Men with Breast Cancer
Advancing Care for Men with Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Advancing Care for Men with Breast Cancer
- Jose Pablo Leone, MD
Risk-Adapted Screening Offers Viable Alternative for Colorectal Cancer
Risk-Adapted Screening Offers Viable Alternative for Colorectal Cancer
Clinician's Roundtable
Risk-Adapted Screening Offers Viable Alternative for Colorectal Cancer
Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
Project Oncology®
Retifanlimab Across POD1UM-303 Subgroups in Squamous Cell Carcinoma of the Anal Canal
- Charles Turck, PharmD, BCPS, BCCCP
- Marwan G. Fakih, MD
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
Project Oncology®
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Project Oncology®
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
AudioAbstracts
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
- Ryan Quigley

Clinical Practice

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

Clinical Practice

Popular

Title

Welcome to the newGlobal Oncology Academy website.

Welcome to the new
Global Oncology Academy website.